• PatientsLikeMe partnered with Biogen on a study of the use of FitBits for MS patients to better assess mobility in between doctor visits. The 21-day study of 248 PatientsLikeMe patients found a high rate of use and perceived ease of use. Two-thirds (68%) agreed that the device would be useful to them in managing their MS, and 83% said they would continue to use it. PatientsLikeMe also inked a five-year deal with AstraZeneca.
  • Several of the initial wave of medical apps for the Apple Watch aim to improve adherence, including medication reminder apps from WebMD and Walgreens. There's also apps from virtual visits service HealthTap and, for doctors, from physician social network Doximity.
  • WSJ on Apple's ResearchKit: "Academic researchers doing similar trials might need several years to enroll only a few hundred patients. Pharmaceutical companies need scores of research sites and hundreds of millions of dollars to find 20,000 patients for a major drug trial."
  • US Rx drug spending jumped 13% last year, to $374 billion, thanks chiefly to the newer hep C drugs and the end of the “patent cliff (but don’t worry – there’s always another one coming!).”
  • Physician photo-sharing app Figure 1 is getting a lot of press. It’s been called “Instagram for doctors,” who can post, say, a picture of a mysterious rash and get other doctors’ input.

Figure 1 is an Instagram for doctors, allowing them to share medical photos. Photo Credit: Figure 1

  • It's not just pharma that's having trouble shifting to a more consumer-oriented approach: “As the consumer is becoming more influential in the healthcare space, a lot of the traditional B2B players, whether that’s providers or insurers, need to have a much more consumer-facing orientation, and a technology that can help them make that transition is great."

Pivoting a product launch during the pandemic

View Now